School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, People's Republic of China.
Bioorg Med Chem. 2011 Mar 15;19(6):2074-83. doi: 10.1016/j.bmc.2011.01.043. Epub 2011 Feb 1.
Cyclooxygenase-1/2 (COX-1/2) and 5-lipoxygenase (5-LOX) are enzymes in two different pathways in the inflammatory process. In the present study, a variety of new nimesulide derivatives were synthesized through incorporation of a 5-LOX pharmacophore into nimesulide followed with some structural modifications, which were then characterized for dual enzyme inhibitors for these two types of enzymes. Their structure-activity relationships (SARs) were studied, and compound 20f was found to be an excellent dual enzyme inhibitor. Its binding conformation and interaction mode were studied with molecular docking experiments. Compound 20f could become a lead compound for further development for potential anti-inflammatory drugs.
环氧合酶-1/2(COX-1/2)和 5-脂氧合酶(5-LOX)是炎症过程中两条不同途径的酶。在本研究中,通过将 5-LOX 药效团引入尼美舒利并进行一些结构修饰,合成了多种新型尼美舒利衍生物,然后对这两种酶的双重酶抑制剂进行了表征。研究了它们的构效关系(SAR),发现化合物 20f 是一种优秀的双重酶抑制剂。通过分子对接实验研究了其结合构象和相互作用模式。化合物 20f 可能成为进一步开发潜在抗炎药物的先导化合物。